Introduction RongCan Biotech is dedicated to the advancement and large-scale production of nucleic acid-based therapies. The company aims to establish itself as a comprehensive industry player, encompassing mRNA sequential design and synthesis, LNP-based delivery systems, and finished mRNA-based pharmaceutical products. As a pioneering domestic R&D enterprise in the field of innovative nucleic acid-based medicines, RongCan Biotech has developed its own proprietary RNA-based Therapeutic Platform (RTP) for the development of mRNA-based vaccines and therapeutics to address critical medical needs. |